| Palladium‐Catalyzed Asymmetric Decarboxylative Cycloaddition of Vinylethylene Carbonates with Michael Acceptors: Construction of Vicinal Quaternary Stereocenters A Khan, L Yang, J Xu, LY Jin, YJ Zhang Angewandte Chemie 126 (42), 11439-11442, 2014 | 246 | 2014 |
| Neurotrophic natural products: chemistry and biology J Xu, MH Lacoske, EA Theodorakis Angewandte Chemie International Edition 53 (4), 956-987, 2014 | 128* | 2014 |
| Nature-inspired total synthesis of (−)-fusarisetin A J Xu, EJE Caro-Diaz, L Trzoss, EA Theodorakis Journal of the American Chemical Society 134 (11), 5072-5075, 2012 | 128 | 2012 |
| Renal clearable luminescent gold nanoparticles: from the bench to the clinic M Yu, J Xu, J Zheng Angewandte Chemie International Edition 58 (13), 4112-4128, 2019 | 127 | 2019 |
| Enantioselective Formal Synthesis of (−)-Englerin A via a Rh-catalyzed [4+ 3] Cycloaddition Reaction J Xu, EJE Caro-Diaz, EA Theodorakis Organic letters 12 (16), 3708, 2010 | 107 | 2010 |
| Metal‐Catalyzed Asymmetric Michael Addition in Natural Product Synthesis C Hui, F Pu, J Xu Chemistry–A European Journal 23 (17), 4023-4036, 2017 | 106 | 2017 |
| Proximity‐enabled protein crosslinking through genetically encoding haloalkane unnatural amino acids Z Xiang, VK Lacey, H Ren, J Xu, DJ Burban, PA Jennings, L Wang Angewandte Chemie International Edition 53 (8), 2190-2193, 2014 | 106 | 2014 |
| Tailoring renal clearance and tumor targeting of ultrasmall metal nanoparticles with particle density S Tang, C Peng, J Xu, B Du, Q Wang, RD Vinluan III, M Yu, MJ Kim, ... Angewandte Chemie 128 (52), 16273-16277, 2016 | 104 | 2016 |
| Gallic acid disruption of Aβ1–42 aggregation rescues cognitive decline of APP/PS1 double transgenic mouse M Yu, X Chen, J Liu, Q Ma, Z Zhuo, H Chen, L Zhou, S Yang, L Zheng, ... Neurobiology of Disease 124, 67-80, 2019 | 94 | 2019 |
| Tuning the in vivo transport of anticancer drugs using renal‐clearable gold nanoparticles C Peng, J Xu, M Yu, X Ning, Y Huang, B Du, E Hernandez, P Kapur, ... Angewandte Chemie International Edition 58 (25), 8479-8483, 2019 | 92 | 2019 |
| Enantioselective total synthesis of (−)-jiadifenolide J Xu, L Trzoss, WK Chang, EA Theodorakis Angewandte Chemie (International ed. in English) 50 (16), 3672, 2011 | 87 | 2011 |
| Dose dependencies and biocompatibility of renal clearable gold nanoparticles: from mice to non‐human primates J Xu, M Yu, C Peng, P Carter, J Tian, X Ning, Q Zhou, Q Tu, G Zhang, ... Angewandte Chemie 130 (1), 272-277, 2018 | 80 | 2018 |
| In vivo X‐ray imaging of transport of renal clearable gold nanoparticles in the kidneys J Xu, M Yu, P Carter, E Hernandez, A Dang, P Kapur, JT Hsieh, J Zheng Angewandte Chemie International Edition 56 (43), 13356-13360, 2017 | 76 | 2017 |
| Total synthesis of astellatol N Zhao, S Yin, S Xie, H Yan, P Ren, G Chen, F Chen, J Xu Angewandte Chemie International Edition 57 (13), 3386-3390, 2018 | 66 | 2018 |
| Illicium Sesquiterpenes: Divergent Synthetic Strategy and Neurotrophic Activity Studies L Trzoss, J Xu, MH Lacoske, WC Mobley, EA Theodorakis Chemistry–A European Journal 19 (20), 6398-6408, 2013 | 64 | 2013 |
| Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles C Peng, X Gao, J Xu, B Du, X Ning, S Tang, RM Bachoo, M Yu, WP Ge, ... Nano research 10, 1366-1376, 2017 | 61 | 2017 |
| Utilization of bio-based glycolaldehyde aqueous solution in organic synthesis: application to the synthesis of 2, 3-dihydrofurans J Xu, W Huang, R Bai, Y Queneau, F Jérôme, Y Gu Green chemistry 21 (8), 2061-2069, 2019 | 60 | 2019 |
| A Concise Total Synthesis of (−)‐Himalensine A Y Chen, J Hu, LD Guo, W Zhong, C Ning, J Xu Angewandte Chemie International Edition 58 (22), 7390-7394, 2019 | 58 | 2019 |
| Fusarisetin A: Scalable Total Synthesis and Related Studies J Xu, EJE Caro-Diaz, MH Lacoske, CI Hung, C Jamora, EA Theodorakis Chemical Science, 2012 | 58 | 2012 |
| Renal clearable noble metal nanoparticles: photoluminescence, elimination, and biomedical applications J Xu, C Peng, M Yu, J Zheng Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (5), e1453, 2017 | 55 | 2017 |
E TheodorakisUniversity of California, San DiegoDirección de correo verificada de ucsd.edu
